A global perspective of Lp(a) levels in patients with coronary heart disease - Implications for risk factor control & future trials from the INTERASPIRE Study

1 September 2024 (14:35 - 14:47)

Organised by:

Video

Sign in to view the resources

Slides

About the speaker

Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail

LDL-Cholesterol levels and lipid lowering therapy in secondary prevention patients: preliminary data from BRING-UP Prevention Study

Doctor A. Maggioni (Florence, IT)

Presentation thumbnail

Suboptimal Lipid Measurement and Statin Use after Percutaneous Coronary Intervention is associated with Increased Mortality: Results of a Real World Registry of 76,264 Patients in NW London

Doctor M. Akhtar (London, GB)

Presentation thumbnail

Intensive, early and sustained lowering of atherogenic lipoproteins after myocardial infarction and long-term prognosis: a nationwide cohort study of myocardial infarction patients

Ms J. Schubert (Uppsala, SE)

Presentation thumbnail

Association of early versus late use of combination lipid-lowering therapy with major cardiovascular outcomes after myocardial infarction: data from the SWEDEHEART registry

Associate Professor M. Leosdottir (Malmo, SE)

Presentation thumbnail

Optimising oral lipid-lowering therapy regimens in high and very high-risk statin intolerant patients with dyslipidaemia: A French real-world simulation

Professor F. Schiele (Besancon, FR)

Access the full session

Session thumbnail

Registries, observational, and other studies on lipids

The Event

Event poster

ESC Congress 2024

1 September 2024 14:35 CET

You may be interested in

Congress Session

Controversies in lipoprotein(a)

Congress Session

Late-Breaking Clinical Science: lipids and cardiovascular risk

Congress Presentation

Prevalence of elevated lipoprotein(a) in premature ASCVD patients and its association with major adverse cardiovascular events: analysis of a large US electronic health record database

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources